Genetic Biotechnology - Search News

News

23andMe Found a Buyer for Our Genetic Data

Fast Company on MSN · 3d

23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals

Announcing the $256 million deal, the New York-based biotech firm vowed to comply with 23andMe’s privacy policy, which was a condition of the sale. Genetic data was on the auction block, and a U.S. biotech company ponied up the cash.

Houston Chronicle on MSN · 2d

Pharmaceutical company Regeneron buying 23andMe for $256 million

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news release. Regeneron’s purchase does not include 23andMe’s Lemonaid Health business.

23andMe Has Found a Buyer—Here’s What Might Happen to Your Genetic Data

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy standards.

3don MSN

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...

GEN - Genetic Engineering and Biotechnology News20h

A Suite of Enhancer AAVs Support Targeted Gene Therapy for Brain Disease

Researchers have developed a new suite of genetic tools for cell-type specific targeting to battle brain disease.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results